Lactobacillus rhamnosus Lb102 and Bifidobacterium Bf141 showed good results in the treatment of obesity and in metabolic syndrome, with a reduction in visceral fat and inflammation, and an improvement in glucose tolerance and insulin sensitivity. This evidence concerns the gene INS and metabolic syndrome.